Product Information
RAMELTEON 8 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6598 per EA under NDC 59651050530. Its NADAC has been published 138 times since Feb 14, 2024.
FDA first approved this application on Jul 10, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651050530
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
RAMELTEONApproval Type
Generic (ANDA)
FDA Application
ANDA215972FDA Approved
7/10/2023
TE Code
AB
On Market Since
7/10/2023
Pharmacological Classes
Price Statistics
The NADAC for RAMELTEON 8 MG TABLET has been published 138 times since Feb 14, 2024, and over the history we have for it it has declined 28.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6598 per EA |
|---|---|
| All-time high | $0.9280 (Feb 14, 2024) |
| All-time low | $0.5491 (Nov 20, 2024) |
| 52-week high | $0.7622 |
| 52-week low | $0.6575 |
| Median price | $0.7443 |
| Average price | $0.7402 |
| Largest weekly change | +50.1% (Aug 21, 2024) |
| Weeks tracked | 138 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
RAMELTEON market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Melatonin Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RAMELTEON 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RAMELTEON 8 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.6598 per EA (NDC 59651050530), effective Sep 30, 2026.
How has the price of RAMELTEON 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for RAMELTEON 8 MG TABLET has declined 28.9%. It has been tracked across 138 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for RAMELTEON 8 MG TABLET?
Since Feb 14, 2024, the NADAC for RAMELTEON 8 MG TABLET has ranged from a low of $0.5491 (Nov 20, 2024) to a high of $0.9280 (Feb 14, 2024), with a median of $0.7443 per EA.
Are there cheaper alternatives to RAMELTEON 8 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RAMELTEON 8 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RAMELTEON 8 MG TABLET?
RAMELTEON 8 MG TABLET (NDC 59651050530) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.